ReducingEthical and SocialPrejudicialEffects of COVID-19Testing in UnderservedPopulations (RESPECT-UP)
Project Number1U01MD017432-01
Former Number1U01AG077342-01
Contact PI/Project LeaderOATES, GABRIELA R Other PIs
Awardee OrganizationUNIVERSITY OF ALABAMA AT BIRMINGHAM
Description
Abstract Text
Prior epidemiologic research by our team documented stark racial and socioeconomic disparities in COVID-19
case prevalence, testing rates, and test positivity in Alabama. COVID-19testing in vulnerable populations is
paramount for current and future pandemic control and critical for reducingCOVID-19 disparities. ReducingEthical and SocialPrejudicialEffects of COVID-19Testing in UnderservedPopulations (RESPECT-UP) aims
to understand and address the social, ethical, and behavioral factors surrounding COVID-19testing in highly
vulnerable urban and rural African American communities in Alabama, in the top quintile of the Social
Vulnerability Index. The targeted geographic areas in Jefferson County (urban) and Dallas County (rural) have
some of the lowest vaccination rates in the country, making their population a very high risk for future disease
outbreaks. In Aim 1, we employ a sequential explanatory mixed methods design to assess social and structural
barriers to COVID-19testing while exploring stigma, discrimination, and behavioral factors that impact COVID-
19 testing intentions in the context of vaccine availability. In Aim 2, we develop actionable strategies to reduce
inequities in COVID-19testing and produce RESPECT-UP Toolkits tailored to various organizational and
community contexts. In Aim 3, we deploy the toolkits and evaluate their effectiveness in urban and rural
primary care settings; implementation in other settings will be evaluated in future efforts. Informed by a Social
Determinants of Health framework and the Theory of Planned Behavior, this systematic approach to
understanding the full continuum of structural, social, ethical, and behavioral determinants of COVID-19testing
generates important new scientific knowledge. Furthermore, working together with community stakeholders in
a participatory way, the project produces concrete multi-level solutions – RESPECT-UP Toolkits – that can be
used by organizations, communities, and policy makers to improve the equity, access, and uptake of current
COVID-19testing and be ready to deliver equitable, non-stigmatizing, and non-discriminatory testing in future
outbreaks. The Toolkits can be adapted to a variety of populations and settings, which further increases their
value, generalizability, sustainability, and potential impact. RESPECT-UP is supported by a community
coalition of partners with a long-standing history of collaboration, and coordinates efforts with other COVID-19
research initiatives to maximize resources, community partnerships, and collected data.
Public Health Relevance Statement
PROJECT NARRATIVE
The COVID-19 pandemic has created unique challenges for vulnerable populations in underserved
communities and unique opportunities to understand how best to improve access to and rates of COVID-19testing and follow-up care. The overall goal of ReducingEthical and SocialPrejudicialEffects of COVID-19Testing in UnderservedPopulations (RESPECT-UP) is to understand and address the social, ethical, and
behavioral implications of COVID-19testing in vulnerable urban and rural racially diverse populations in
Alabama.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdultAfrican American populationAlabamaAttitudeBehaviorBehavior ControlBehavioralCOVID-19COVID-19 disparityCOVID-19 impactCOVID-19 pandemicCOVID-19testingCOVID-19 vaccinationCOVID-19 vaccineCaringCenters for Disease Control and Prevention (U.S.)ChurchCollaborationsCommunitiesContact TracingCountryCountyCrowdingDataDevelopmentDiscriminationDisease OutbreaksEffectivenessEmploymentEthicsEthnic groupFocus GroupsFoodFutureGeneral PopulationGeographic LocationsGeographyGoalsHealth PersonnelHealth PolicyHourHousingImprove AccessInstitutionInstitutional PracticeInterviewKnowledgeLocationLogisticsMapsMethodologyMethodsMisinformationMississippiNeighborhoodsOccupationsPhasePlanning TheoryPoliciesPolicy MakerPoliticsPopulationPopulation HeterogeneityPrevalencePublic HealthRADx UnderservedPopulationsRaceRecommendationRecording of previous eventsReligion and SpiritualityResearchResourcesRuralSARS-CoV-2 infectionScheduleSiteSocial WorkStigmatizationSurveysTestingTrainingTransportationTrustUnderserved PopulationVaccinatedVaccinationViralVirusVulnerable Populationsasymptomatic COVID-19authoritybasecommunity engagementcommunity organizationscommunity partnershipcoronavirus diseasecostdesigneducation resourcesepidemiology studyexperiencefollow-uphigh riskhuman centered designimplementation evaluationimplementation outcomesimplementation scienceimprovedindexinginformantmarginalized communityoperationpandemic diseaseperceived discriminationpreventprimary care settingracial disparityracial diversityrural African Americanservice organizationsocialsocial health determinantssocial stigmasocial structuresocial vulnerabilitysocioeconomic disparitystemsymptomatic COVID-19underserved communityuptakevaccine access
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
063690705
UEI
YND4PLMC9AN7
Project Start Date
01-January-2022
Project End Date
30-November-2023
Budget Start Date
01-January-2022
Budget End Date
30-November-2022
Project Funding Information for 2022
Total Funding
$594,000
Direct Costs
$400,000
Indirect Costs
$194,000
Year
Funding IC
FY Total Cost by IC
2022
NIH Office of the Director
$594,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01MD017432-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01MD017432-01
Patents
No Patents information available for 1U01MD017432-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01MD017432-01
Clinical Studies
No Clinical Studies information available for 1U01MD017432-01
News and More
Related News Releases
No news release information available for 1U01MD017432-01
History
No Historical information available for 1U01MD017432-01
Similar Projects
No Similar Projects information available for 1U01MD017432-01